Rhabdomyosarcoma in a child with nephrotic syndrome treated with cyclosporine: a case report with literature review.

作者: Huai-Chueh Gem Wu , Chao-Neng Cheng , Jiann-Shiuh Chen , Yuan-Yow Chiou

DOI: 10.1186/S12882-020-02136-6

关键词:

摘要: In patients with frequently relapsing nephrotic syndrome, immunosuppressive therapy such as cyclosporine are often required to maintain remission. Cyclosporine has been noted have tumorgenesis effects. this case report, we present a child syndrom developed rhabdomyosarcoma on her tongue after adout 4 years of continual therapy. A 2-year-old female had syndrome (urine protein-creatinine ratio 749.1 mg/mg; blood urea nitrogen 11 mg/dL; serum creatinine 0.3 mg/dL; and albumin 1.8 g/dL.) Proteinuria resolved treatment daily prednisolone for weeks at the dose 45 mg (2.5 mg/kg/day) but recurred taper from 25 mg/day 10 mg/day. At least five more episodes relapse occurred within about 3-year period. After third relapse, she was treated (at initial 50 mg/day [1.7 mg/kg/day]) immunosuppression. About diagnosis made, an embryonal tongue. The cancer TPOG-RMS-LR protocol, vincristine, actinomycin, cyclophosphamide. Magnetic resonance imaging scan, performed 3 start therapy, revealed complete remission cancer. Although cannot be conclusively implicated cause in patient, association should prompt consideration its use children.

参考文章(21)
Minoru Hojo, Takashi Morimoto, Mary Maluccio, Tomohiko Asano, Kengo Morimoto, Milagros Lagman, Toshikazu Shimbo, Manikkam Suthanthiran, Cyclosporine induces cancer progression by a cell-autonomous mechanism Nature. ,vol. 397, pp. 530- 534 ,(1999) , 10.1038/17401
Christiane Kuschal, Kai-Martin Thoms, Lars Boeckmann, Petra Laspe, Antje Apel, Michael P. Schön, Steffen Emmert, Cyclosporin A inhibits nucleotide excision repair via downregulation of the xeroderma pigmentosum group A and G proteins, which is mediated by calcineurin inhibition. Experimental Dermatology. ,vol. 20, pp. 795- 799 ,(2011) , 10.1111/J.1600-0625.2011.01320.X
N. André, B. Roquelaure, J. Conrath, Molecular effects of cyclosporine and oncogenesis: a new model Medical Hypotheses. ,vol. 63, pp. 647- 652 ,(2004) , 10.1016/J.MEHY.2004.03.030
K. Ishikura, M. Ikeda, S. Hattori, N. Yoshikawa, S. Sasaki, K. Iijima, K. Nakanishi, N. Yata, M. Honda, Effective and safe treatment with cyclosporine in nephrotic children: a prospective, randomized multicenter trial. Kidney International. ,vol. 73, pp. 1167- 1173 ,(2008) , 10.1038/KI.2008.24
Matteo Cescon, Gian Luca Grazi, Giorgio Ercolani, Antonino Cavallari, Roberto Assietti, Francesca Sparacio, Franco Frigerio, Alberto Scanni, Embryonal rhabdomyosarcoma of the orbit in a liver transplant recipient Transplant International. ,vol. 16, pp. 437- 440 ,(2003) , 10.1007/S00147-003-0571-9
M. Muramatsu, Satoshi Kotake, Koji Yoshikawa, Yoichi Sasamoto, Hidehiko Matsuda, Shinya Yamawaki, The development of malignant rhabdoid tumor in a patient with Behçet’s disease treated with ciclosporin Graefes Archive for Clinical and Experimental Ophthalmology. ,vol. 236, pp. 798- 799 ,(1998) , 10.1007/S004170050162
Stephanie B. Walsh, Jianmin Xu, Hui Xu, Ashish R. Kurundkar, Akhil Maheshwari, William E. Grizzle, Laura Timares, Conway C. Huang, Levy Kopelovich, Craig A. Elmets, Mohammad Athar, Cyclosporine a mediates pathogenesis of aggressive cutaneous squamous cell carcinoma by augmenting epithelial-mesenchymal transition: role of TGFβ signaling pathway. Molecular Carcinogenesis. ,vol. 50, pp. 516- 527 ,(2011) , 10.1002/MC.20744
Barry D Kahan, Yarkin K Yakupoglu, Linda Schoenberg, Richard J Knight, Stephen M Katz, Deijan Lai, Charles T Van Buren, None, Low incidence of malignancy among sirolimus/cyclosporine-treated renal transplant recipients Transplantation. ,vol. 80, pp. 749- 758 ,(2005) , 10.1097/01.TP.0000173770.42403.F7
Wasiu Adekunle Olowu, Abdulkadr Ayo Salako, Kayode Adebowale Adelusola, Oludayo Adedapo Sowande, Victor Adebayo Adetiloye, Olufemi Adefehinti, Stephen Adebayo Osasan, Focal segmental glomerulosclerosis and nephrotic syndrome in a child with embryonal rhabdomyosarcoma Clinical and Experimental Nephrology. ,vol. 12, pp. 144- 148 ,(2008) , 10.1007/S10157-007-0015-4